Global In virtro diagnostic quality controls market studied at regional and country levels. In 2016, North America represented largest regional market, followed by Europe, Asia-Pacific, Latin America, & Middle East & Africa. North America will continue to dominate global In Vitro Diagnostics Quality Controls Market, Asia-Pacific region expected to be fastest-growing geographic market in coming years.
The global IVD Quality Controls Market expected to reach USD 1.04 Billion by 2022, at a CAGR of 3.5% from 2017 to 2022. In this report, IVD quality controls market segmented by product & service, application, end user, manufacturer type, & region. On basis of product & service, market segmented into quality controls, data management solutions, & quality assurance services. In 2016, quality controls segment accounted for largest share of market.
Complete Report on In Vitro Diagnostics Quality Control Market spread across 200 Pages, Profiling 12 Companies and Supported with 162 Tables and 36 Figures is now available at http://www.reportsnreports.com/reports/515130-in-vitro-diagnostics-ivd-quality-controls-market-by-application-immunoassay-clinical-chemistry-molecular-diagnostics-microbiology-source-serum-blood-plasma-based-controls-type-instrument-specific-third-party-controls-forecast-to-2020.html .
In Vitro Diagnostics Quality Control Market report aims to estimate size & future growth potential of the IVD Quality Controls Market across different segments like product & service, application, manufacturer type, end user, & region. Third-party quality controls segment expected to grow at highest CAGR during forecast period. This growth can be attributed to increasing use of third-party quality controls across globe to verify patient test results.
Target Audience In vitro diagnostic quality control market
- IVD product manufacturers
- Group purchase organizations (GPOs)
- OEM manufacturers
- Pathologists and pathology laboratories
- Distributors of IVD quality control products
- Hospitals and clinics
- Healthcare institutions
- Research institutes
- Market research and consulting firms
- Venture capitalists and investors
In Vitro Diagnostics Quality Controls Market segmented into clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation/hemostasis, microbiology. Immunochemistry segment accounted for largest share of In Vitro Diagnostics Quality Controls Market. This mainly due to increasing number of multi-analyte controls to perform immunoassay tests. Molecular diagnostics segment expected to grow at highest CAGR during forecast period, mainly due to increasing number of molecular diagnostic tests performed in laboratories & need to ensure accuracy of these complex diagnostic tests.
Click Now for PDF Sample Download of this Study Report
Major players in In Vitro Diagnostics quality controls market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Randox Laboratories (U.K.), Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Siemens Healthcare (Germany), and Sysmex Corporation (Japan).
1 Visionary Leaders
3 Emerging Companies
4 Dynamic Differentiators
5 Competitive Benchmarking
6 Product Offerings
7 Business Strategy
8 Market Share Analysis
Growth in global In Vitro Diagnostics Quality Controls Market mainly driven by factors like increasing number of accredited clinical laboratories & growing adoption of third-party quality controls to ensure unbiased test results. Increasing use of multi-analyte controls & increasing focus of key players on emerging countries are creating new growth opportunities for market.
Connect for More Details for Discount and More Information “Medical Device Cleaning Market by Process (Presoak, Manual Cleaning, Automatic Cleaning, Disinfection) Type (Enzymatic & Non-enzymatic Detergent) Application (Surgical Instruments, Endoscope, Ultrasound Probe) – Global Forecast to 2022” report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=515130 .
Key insights & market sizing for different end users of IVD quality controls market namely, hospitals, laboratories, research & academic institutes, & other end users. The report also provides information on key players in this market and their growth strategies and recent developments.
Some of factors like unfavourable reimbursement scenario for IVD tests, additional costs involved in quality control process, & budget constraints in hospitals & laboratories are expected to restrain growth of this market during forecast period. Report also provides information on key players in this market & their growth strategies & recent developments. This can help company to assess competition at global & regional levels in a better manner.